• 1
    Bumgardner GL, Gao D, Li J, Baskin J, Heininger M, Orosz CG. Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4 KO, and CD8 KO mice. Transplantation 2000; 70: 17711780.
  • 2
    Gao D, Li J, Orosz C, Bumgardner G. Different costimulation signals used by CD4+ and CD8+ cells that independently initiate rejection of allogeneic hepatocytes in mice. Hepatology 2000; 32: 10181028.
  • 3
    Newell KA, He G, Guo Z et al. Blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells. J Immunol 1999; 163: 23582362.
  • 4
    He G, Hart J, Kim OS et al. The role of CD8 and CD4 T cells in intestinal allograft rejection: A comparison of monoclonal antibody-treated and knockout mice. Transplantation 1999; 67: 131137.
  • 5
    Guo Z, Wang J, Meng L et al. Cutting edge: Membrane lyphotoxin regulates CD8+ T cell-mediated intestinal allograft rejection. J Immunol 2001; 167: 47964800.
  • 6
    Guo Z, Meng L, Kim O et al. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway. Transplantation 2001; 71: 13511354.
  • 7
    Trambley J, Bingaman AW, Lin A et al. Asialo GM1 +CD8+ T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 1999; 104: 17151722.
  • 8
    Han WR, Zhan Y, Murray-Segal LJ, Brady JL, Lew AM, Mottram PL. Prolonged allograft survival in anti-CD4 antibody transgenic mice: Lack of residual helper T cells compared with other CD4-deficient mice. Transplantation 2000; 70: 168174.
  • 9
    Bishop DK, Wood SC, Eichwald EJ, Orosz CG. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 Ligand interactions. J Immunol 2001; 166: 32483255.
  • 10
    Jones ND, Van Maurik A, Hara M et al. CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection. J Immunol 2000; 165: 11111118.
  • 11
    Lunsford KE, Gao D, Eiring AM, Wang Y, Frankel WL, Bumgardner GL. Evidence for tissue directed immune responses: Analysis of CD4-dependent and CD8-dependent alloimmunity. Transplantation 2004; 78: 11251133.
  • 12
    Diamond AS, Gill RG. An essential contribution by IFN-gamma to CD8+ T cell-mediated rejection of pancreatic islet allografts. J Immunol 2000; 165: 247255.
  • 13
    Lunsford KE, Horne PH, Koester MA et al. Activation and maturation of alloreactive CD4-independent, CD8+ cytolytic T cells. Am J Transplantation 2006; 6: 22682281.
  • 14
    Adams AB, Williams MA, Jones TR et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003; 111: 18871895.
  • 15
    Adams AB, Pearson TC, Larsen CP. Heterologous immunity: An overlooked barrier to tolerance. Immunol Rev 2003; 196: 147160.
  • 16
    Turgeon NA, Iwakoshi NN, Phillips NE et al. Viral infection abrogates CD8 T-cell deletion induced by costimulation blockade. J Surg Res 2000; 93: 6369.
  • 17
    Welsh RM, Markees TG, Woda BA et al. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody. J Virol 2000; 74: 22102218.
  • 18
    Williams M, Tan J, Adams A et al. Characterization of virus-mediated inhibition of mixed chimerism and allospecific tolerance. J Immunol 2001; 167: 49874995.
  • 19
    Forman D, Welsh RM, Markees TG et al. Viral abrogation of stem cell transplantation tolerance causes graft rejection and host death by different mechanisms. J Immunol 2002; 168: 60476056.
  • 20
    Bowen DG, Warren A, Davis T et al. Cytokine-dependent bystander hepatitis due to intrahepatic murine CD8 T-cell activation by bone marrow-derived cells. Gastroenterology 2002; 123: 12521264.
  • 21
    Ryan EA, Lakey JR, Paty BW et al. Successful islet transplantation: Continued insulin reserve provides long-term glycemic control. Diabetes 2002; 51: 21482157.
  • 22
    Ryan EA, Paty BW, Senior PA et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 20602069.
  • 23
    Alters SE, Shizuru JA, Ackerman J, Grossman D, Seydel KB, Fathman CG. Anti-CD4 mediates clonal anergy during transplantation tolerance induction. J Exp Med 1991; 173: 491494.
  • 24
    Yamamoto H, Monden M, Kawai M et al. The role of CD8+ and CD4+ cells in islet allograft rejection. Transplantation 1990; 50: 120125.
  • 25
    Gill RG, Rosenberg AS, Lafferty KJ, Singer A. Characterization of primary T cell subsets mediating rejection of pancreatic islet grafts. J Immunol 1989; 143: 21762178.
  • 26
    Rossini AA, Parker DC, Phillips NE et al. Induction of immunological tolerance to islet allografts. Cell Transplantation 1996; 5: 4952.
  • 27
    Parker DC, Greiner DL, Phillips NE et al. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci USA 1995; 92: 95609564.
  • 28
    Zheng XX, Markees TG, Hancock WW et al. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment. J Immunol 1999; 162: 49834990.
  • 29
    Chahine AA, Yu M, McKernan MM, Stoeckert C, Lau HT. Immunomodulation of pancreatic islet allografts in mice with CTLA-4Ig secreting muscle cells. Transplantation 1995; 9: 13131318.
  • 30
    Rastellini C, Salam A, Kuddus R et al. Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40 L monoclonal antibody results in indefinite islet allograft survival. Transplant Proc 1999; 31: 12421243.
  • 31
    Nicolls MR, Coulombe M, Yang H, Bolwerk A, Gill RG. Anti-LFA-1 Therapy induces long-term islet allograft acceptance in the absence of IFN-gamma or IL-4. The J Immunol 2000; 164: 36273634.
  • 32
    Arai K, Sunamura M, Wada Y et al. Preventing effect of anti-ICAM-1 and anti-LFA-1 monoclonal antibodies on murine islet allograft rejection. Int J of Pancreatol 1999; 26: 2331.
  • 33
    Nicolls MR, Coulombe M, Beilke J, Gelhaus HC, Gill RG. CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 Pathways. J Immunol 2002; 169: 48314839.
  • 34
    Berney T, Pileggi A, Molano RD et al. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice. Transplantation 2003; 76: 16691674.
  • 35
    Bumgardner GL. Evidence for multiple allograft rejection mechanisms within the same experimental system. Curr Opin Organ Transplant 2005; 10: 2027.
  • 36
    Bumgardner GL, Li J, Prologo JD, Heininger M, Orosz CG. Patterns of immune responses evoked by allogeneic hepatocytes: Evidence for independent co-dominant roles for CD4+ and CD8+ T-cell responses in acute rejection. Transplantation 1999; 68: 555562.
  • 37
    Bumgardner GL, Heininger M, Li J et al. A functional model of hepatocyte transplantation for in vivo immunologic studies. Transplantation 1998; 65: 5361.
  • 38
    Wang Y, Gao D, Lunsford KE, Frankel WL, Bumgardner GL. Targeting LFA-1 synergizes with CD40/CD40 L blockade for suppression of both CD4-dependent and CD8-dependent rejection. Am J Transplant 2003; 3: 12511258.
  • 39
    Bumgardner GL, Chen S, Almond PS, Bach FH, Ascher NL, Matas AJ. Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. I. The role of L3T4+ T cells in the development of allospecific cytotoxicity in hepatocyte sponge matrix allografts. Transplantation 1992; 53: 857862.
  • 40
    Gao D, Lunsford KE, Eiring AM, Bumgardner GL. Critical role for CD8+ T cells in allograft acceptance induced by DST and CD40/CD154 costimulatory blockade. Am J Transplant 2004; 4: 10611070.
  • 41
    Van Stipdonk MJ, Hardenberg G, Bijker MS et al. Dynamic programming of CD8+ T lymphocyte responses. Nat Immunol 2003; 4: 361365.
  • 42
    Oehen S, Brduscha-Riem K. Differentiation of naive CTL to effector and memory CTL: Correlation of effector function with phenotype and cell division. J Immunol 1998; 161: 53385346.
  • 43
    Lunsford KE, Koester MA, Eiring AM, Gao D, Horne PH, Bumgardner GL. Targeting LFA-1 and CD154 suppresses the in vivo activation and development of cytolytic (CD4-independent) CD8+ T cells. J Immunol 2005; 175: 78557866.
  • 44
    Bumgardner GL, Orosz CG. Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells. Immunol Rev 2000; 174: 260279.
  • 45
    Banuelos SJ, Markees TG, Phillips NE et al. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms. Transplantation 2004; 78: 660667.
  • 46
    Horne PH, Koester MA, Jayashankar K, Lunsford KE, Dziema HL, Bumgardner GL. Disparate primary and secondary allospecific CD8+ T cell cytolytic effector function in the presence or absence of host CD4+ T cells. J Immunol 2007; 179: 8088.
  • 47
    Ryan EA, Lakey JR, Rajotte RV et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001; 50: 710719.
  • 48
    Shapiro AM, Ricordi C, Hering B. Edmonton's islet success has indeed been replicated elsewhere. Lancet 2003; 362: 1242.
  • 49
    Shapiro AMJ, Lakey JRT, Ryan E et al. Insulin independence after solitary islet transplantation in type I diabetic patients using steroid-free immunosuppression. Transplantation 2000; 69: s400.
  • 50
    Froud T, Ricordi C, Baidal DA et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005; 5: 20372046.
  • 51
    Christianson SW, Shultz LD, Leiter EH. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Diabetes 1993; 42: 4455.
  • 52
    Bendelac A, Carnaud C, Boitard C, Bach J. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy noenates. Requirement for both L3T4+ and lyt-2+ T-cells. J Exp Med 1987; 166: 823832.
  • 53
    Wang B, Gonzalez A, Benoist C, Mathis D. The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus. Eur J Immunol 1996; 26: 17621769.
  • 54
    Piaggio E, Hartemann-Heurtier A, Cabarrocas J et al. Maintaining or breaking CD8+ T-cell tolerance to beta islet cell antigens: Lessons from transgenic mouse models. J Autoimmun 2004; 22: 115120.
  • 55
    Abraham C, Griffith J, Miller J. The dependence for leukocyte function-associated antigen-1/ICAM-1 interactions in T cell activation cannot be overcome by expression of high density TCR ligand. J Immunol 1999; 162: 43994405.
  • 56
    Ni HT, Deeths MJ, Li W, Mueller DL, Mescher MF. Signaling pathways activated by LFA-1 dependent costimulation. J Immunol 1999; 162: 51835189.
  • 57
    Shier P, Ngo K, Fung-Leung W-P. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling. J Immunol 1999; 163: 48264832.
  • 58
    Chen T, Goldstein JS, O'Boyle K, Whitman MC, Brunswick M, Kozlowski S. ICAM-1 co-stimulation has differential effects on the activation of CD4+ and CD8+ T cells. Eur J Immunol 1999; 29: 809814.
  • 59
    Deeths MJ, Mescher MF. ICAM-1 and B7–1 provide similar but distinct costimulation for CD8+ T cells while CD4+ T cells are poorly costimulated by ICAM-1. Eur J Immunol 1999; 29: 4553.
  • 60
    De Paepe ME, Keymeulen B, Pipeleers D, Kloppel G. Proliferation and hypertrophy of liver cells surrounding islet grafts in diabetic recipient rats. Hepatology 1995; 21: 11441153.
  • 61
    Lee KW, Lee SK, Joh JW et al. Influence of pancreatic islets on spheroid formation and functions of hepatocytes in hepatocyte-pancreatic islet spheroid culture. Tissue Eng 2004; 10: 965977.
  • 62
    Papalois A, Arkadopoulos N, Pataryas TH, Papadimitriou J, Golematis B. Combined hepatocyte-islet transplantation: An allograft model. Transpl Int 1994; 7(1Suppl): S432S435.